MB Therapeutics €2 Million Seed Funding to Support Personalized Medicine Production

by Medical

MB Therapeutics, a Montpellier-based startup with over 8 years of expertise in pharmaceutical 3D printing, has secured €2 million in seed funding to develop the first pharmaceutical facility designed to provide 3D printing compatible solutions for pharmacies. This facility will help pharmacies produce personalized medicines on-site, improving precision and meeting the growing demand for individualized treatments. The funding will also enable the launch of three high-demand medicines and prepare the company for a Series A funding round in 2026.

3D Printed Models Create New Paths for Treating Herpes Simplex Virus (HSV)

by Medical

In the battle against herpes simplex virus (HSV), 3D printing technology is offering a new approach to drug development by creating models of human skin. Current antiviral drugs often fall short because they cannot replicate the complexity of human tissue. To address this, Dr. Jia Zhu from the Fred Hutch Vaccine and Infectious Disease Division, alongside biofabrication experts Dr. Ian Hayman and Dr. Tori Ellison, is using 3D printing to develop these models, enhancing the precision of virus studies.

Auxilium Biotechnologies 3D prints medical devices in Space

by Medical

Auxilium Biotechnologies, a San Diego medtech startup, is 3D printing medical devices in space. The company uses a DLP-based bioprinter called the Auxilium Microfabrication Platform (AMP-1) to create biomimetic devices for nerve injuries. A recent deployment of the AMP-1 to the International Space Station (ISS) resulted in a successful test, described by Auxilium CEO Jacob Koffler as “a landmark achievement for space biomanufacturing.”

Stratasys Expands Digital Denture Solution to Europe

by Medical

Stratasys, a leading provider of 3D printing solutions, has received CE Mark Class I approval for its TrueDent-D resin, enabling the sale of its monolithic multi-shade digital denture solution across Europe. Following its successful U.S. launch in 2023, this milestone allows the company to bring a scalable and efficient solution to European dental labs, dentists, and patients.

3DPI Awards 2024: Frontier Bio’s Lab Grown Lung Tissue

by Medical

Eric Bennett, CEO of Frontier Bio, told us more about 3D printing in regenerative medicine and the development of lab-grown human tissues, aiming to ultimately eliminate the organ transplant waitlist. Frontier Bio’s groundbreaking applications, such as their “brain on a chip” technology, provide humane and highly relevant alternatives to animal studies in traumatic brain injury (TBI) research, with future potential for drug discovery in conditions like Alzheimer’s and Dementia. 

3D Printing Industry Awards 2024: 3D Systems, Medical, Dental, or Healthcare Application of the Year

by Medical

Ahead of this year’s 3DPI Awards, Stijn Hanssen Director of Application Development for Dental at 3D Systems, told us more about developing the industry’s first monolithic jetted denture solution, transforming how dentures are fabricated and delivered. This innovation combines multiple materials in a single print, mimicking the properties of natural teeth and gums to create durable, aesthetically superior, and comfortable prosthetics. Leveraging 3D Systems’ MultiJet printing technology, comprehensive workflow solutions, and decades of expertise in dental materials, this solution streamlines production for high-volume dental labs, reducing complexity, cost, and patient wait times. Collaborations with dental professionals have been integral to refining this technology, resulting in a product that enhances patient outcomes with precise fits, shorter workflows, and exceptional long-term comfort.